Certified by Founder Lodge
Shennon Biotechnologies
United States - San Francisco, California
START UP
1 Disclosed Funding Rounds $13,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 14 ,2023 | Seed | $13,000,000 |
DCVC
Foundation Capital
AV8 Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
MaiaEdge | $20,000,000 | (Feb 4, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
ecovia I bio | Undisclosed Amount | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
